Clarity Medical Systems Inc. has received a patent on optimizing vision correction procedures from the U.S. Patent and Trademark Office.
Pleasanton, CA-Clarity Medical Systems Inc. has received a patent on optimizing vision correction procedures from the U.S. Patent and Trademark Office.
The patent, which is a continuation of Clarity’s expanding HOLOS technology portfolio, includes the capture and display of high accuracy continuous intraoperative wavefront aberrometry.
“We believe this unique capability will provide the opportunity to deploy HOLOS to help ophthalmologists more rapidly and efficiently measure the patient’s refractive state during vision correction procedures, including assisting surgeons as a refractive guidance tool intraoperatively,” said Keith Mullowney, president and chief executive officer of Clarity.
Clarity’s first product application of the technology will be for refractive cataract surgery with HOLOS IntraOp-an intraoperative module that attaches to standard surgical microscopes to assist the surgeon in monitoring and confirming the refractive status of the patient’s eye throughout all phases of the surgical procedure.
For more articles in this issue of Ophthalmology Times eReport, click here.
To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.